Comparisons of Inhaled LAMA or LAMA+LABA or ICS+LABA for COPD With Bronchiectasis
Status:
Unknown status
Trial end date:
2021-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine which treatment is more effective and safer for the
patients in COPD C group with bronchiectasis.The research results will help guide physicians
to select appropriate individualized treatment and hopefully provide some evidence-based
medicine proofs for revising guide.